(RTTNews) - Cingulate (CING) announced that it has received formal pre-New Drug Application meeting minutes from the FDA for its lead asset CTx-1301 for the treatment of Attention ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback